Lilly, Plaintiff Group Settle Zyprexa MDL Claims

Law360, New York (April 7, 2009, 12:00 AM EDT) -- A group of plaintiffs has reached a settlement with Eli Lilly & Co. in the continuing multidistrict litigation over the pharmaceutical company's anti-psychotic drug Zyprexa.

In a Thursday motion in the U.S. District Court for the Eastern District of New York, the plaintiffs and Lilly asked the court to establish a qualified fund for the confidential settlement, appoint a settlement administrator and place the court file under seal.

The plaintiffs, who filed suit in the district court in 2007, alleged that Lilly's misrepresentation of Zyprexa and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.